MetaCap

Biodesix Inc. Company Profile

NASDAQ: BDSXHealth CareMedical SpecialitiesUSD

7.56-0.74 (-8.92%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Biodesix at a glance

Biodesix Inc. (NASDAQ: BDSX) is a Medical Specialities company in the Health Care sector headquartered in Louisville, CO. Biodesix is led by Mr. Scott Hutton and employs about 334 people. The company's shares have traded publicly since 2020.

At a market capitalization of $83.8 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001439725, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Biodesix do?

Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Business description based on the company's public filings.

Company information

Legal name
Biodesix Inc.
Ticker
NASDAQ: BDSX
Industry
Medical Specialities
CEO
Mr. Scott Hutton
Employees
334
Headquarters
919 West Dillon Road, Louisville, CO, United States
Phone
303 417 0500
IPO year
2020
Market cap
$83.83M
SEC CIK
0001439725
Latest annual report
10-K · Feb 26, 2026

Companies similar to Biodesix

BDSX peer companies
CompanyPrice% ChgMarket capCompare
XGNExagen Inc.3.61-5.00%$92.10Mvs BDSX
SERASera Prognostics Inc. Class A1.81-4.23%$71.98Mvs BDSX
KEQUKewaunee Scientific Corporation33.55-2.75%$97.14Mvs BDSX
BNRBurning Rock Biotech Limited ADR13.24-0.60%$139.63Mvs BDSX
TLSITriSalus Life Sciences Inc.2.32+6.67%$143.14Mvs BDSX
MDXHMDxHealth SA0.1074-8.52%$10.25Mvs BDSX
AMSAmerican Shared Hospital Services1.00-4.76%$6.67Mvs BDSX
ACONAclarion Inc.1.22-13.92%$3.52Mvs BDSX

Related